Qube Research & Technologies (QRT)
TEVA icon

Qube Research & Technologies (QRT)’s Teva Pharmaceuticals TEVA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,500
Closed -$78K – 4122
2025
Q4 		$78K Sell
2,500
-2,500
-50% -$61.6K ﹤0.01% 3229
2025
Q3 		$101K Sell
5,000
-19,400
-80% -$341K ﹤0.01% 3064
2025
Q2 		$409K Buy
+24,400
New +$394K ﹤0.01% 2746

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TEVA Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Teva Pharmaceuticals (TEVA) in Q1 2026: 59,306 shares worth $1.79M. The stake represents ﹤0.01% of the portfolio and ranks #2239 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in TEVA as recently as Q1 2025.

Qube Research & Technologies (QRT) first reported a position in TEVA in Q2 2020 and has held it in 13 quarters since. The position peaked at $45.1M in Q1 2025. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Qube Research & Technologies (QRT) held 59,306 shares of Teva Pharmaceuticals worth $1.79M as of Q1 2026.
  • Teva Pharmaceuticals was a new Qube Research & Technologies (QRT) position in Q1 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2239 holding.
  • Qube Research & Technologies (QRT) first reported a position in Teva Pharmaceuticals in Q2 2020 and has held it in 13 quarters since.
  • Qube Research & Technologies (QRT)'s Teva Pharmaceuticals position peaked at $45.1M in Q1 2025.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.